BioNTech and Pfizer begin study to evaluate single dose vaccine against flu and COVID-19

BioNTech and Pfizer announced today the initiation of a Phase 1 study evaluating a single dose mRNA-based combination vaccine candidate against influenza and COVID-19.

More Stories

00:22

Cold Spring Village Hall closed due to COVID-19 surge and staff shortages

Hometown Heroes in the Hudson Valley

Hometown Heroes in New York City

00:33

US Supreme Court rejects appeal on Rutgers University COVID-19 vaccine mandate case

Hometown Heroes in Connecticut

01:28

Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines